Clinical Trial Update: Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) [Phase 2]

View source ↗

Summary

NHLBI-sponsored Systolic Hypertension in the Elderly Program (SHEP) pilot study, a Phase 2 trial, has completed activity under a completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hypertension
• Vascular Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 2 | Status: COMPLETED